# Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases

> **NCT07283315** · EARLY_PHASE1 · RECRUITING · sponsor: **The Children's Hospital of Zhejiang University School of Medicine** · enrollment: 12 (estimated)

## Conditions studied

- Paediatric B Cell-related Autoimmune Diseases
- Autoimmune Diseases
- CAR

## Interventions

- **BIOLOGICAL:** anti-CD19/BCMA CAR NK cells (KN5601-K)

## Key facts

- **NCT ID:** NCT07283315
- **Lead sponsor:** The Children's Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-03
- **Primary completion:** 2028-12-30
- **Final completion:** 2029-12-30
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07283315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07283315, "Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07283315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*